AU2001242750A1 - Novel protein, process for producing the same and use thereof - Google Patents

Novel protein, process for producing the same and use thereof

Info

Publication number
AU2001242750A1
AU2001242750A1 AU2001242750A AU4275001A AU2001242750A1 AU 2001242750 A1 AU2001242750 A1 AU 2001242750A1 AU 2001242750 A AU2001242750 A AU 2001242750A AU 4275001 A AU4275001 A AU 4275001A AU 2001242750 A1 AU2001242750 A1 AU 2001242750A1
Authority
AU
Australia
Prior art keywords
producing
same
novel protein
protein
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242750A
Other languages
English (en)
Inventor
Shunbun Kita
Tomoko Komiyama
Yoshio Taniyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001242750A1 publication Critical patent/AU2001242750A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001242750A 2000-03-24 2001-03-22 Novel protein, process for producing the same and use thereof Abandoned AU2001242750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-88595 2000-03-24
JP2000088595 2000-03-24
PCT/JP2001/002279 WO2001070974A1 (fr) 2000-03-24 2001-03-22 Nouvelle proteine, son procede de production et d'utilisation

Publications (1)

Publication Number Publication Date
AU2001242750A1 true AU2001242750A1 (en) 2001-10-03

Family

ID=18604452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242750A Abandoned AU2001242750A1 (en) 2000-03-24 2001-03-22 Novel protein, process for producing the same and use thereof

Country Status (3)

Country Link
EP (2) EP1698697A3 (fr)
AU (1) AU2001242750A1 (fr)
WO (1) WO2001070974A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003252026A1 (en) * 2002-07-19 2004-02-09 Schering Corporation Npc1l1 (npc3) and methods of use thereof
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
US20040132058A1 (en) * 2002-07-19 2004-07-08 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
EP1723414A4 (fr) 2004-01-16 2008-03-26 Merck & Co Inc Npc1l1 (npc3) et procedes pour identifier des ligands de ceux-ci
CA2579790A1 (fr) * 2004-07-30 2006-02-09 Mount Sinai School Of Medicine Of New York University Inhibiteurs de npc1l1 et npc1l1 et procedes d'utilisation associes
WO2007100807A2 (fr) 2006-02-24 2007-09-07 Schering Corporation Orthologues de npc1l1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
ATE257861T1 (de) 1993-09-27 2004-01-15 Arch Dev Corp Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung
WO1999001555A1 (fr) * 1997-07-03 1999-01-14 The United States Of America Represented By The Secretary, Department Of Health And Human Services Genes de la maladie de niemann-pick de type c
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
EP1698697A2 (fr) 2006-09-06
WO2001070974A1 (fr) 2001-09-27
EP1698697A3 (fr) 2006-09-13
EP1273657A1 (fr) 2003-01-08
EP1273657A4 (fr) 2005-04-06

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU2001236148A1 (en) Polyorganosilsesquioxane and process for preparing the same
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2001274511A1 (en) Adsorbent, process for producing the same, and applications thereof
AU2002349477A1 (en) Bicyclic derivative, process for producing the same, and use
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
AU2001294228A1 (en) Benzimidazole compounds, process for producing the same and use thereof
AU2001292320A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor
AU2002318742A1 (en) Pullulan-containing powder, process for producing the same and use thereof
AU2001289695A1 (en) Impregnate, method for the production and use thereof
AU2001242795A1 (en) Condensed pyrazole derivatives, process for producing the same and use thereof
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU6730001A (en) Component, method for production and use thereof
AU2001266326A1 (en) Polypeptides, use thereof and process for producing the same
AU5447899A (en) Novel protein and process for producing the same
AU2002216364A1 (en) Novel substance fki-1083 and process for producing the same
AU2001227071A1 (en) Novel substance m-17a and process for producing the same
AU2000228300A1 (en) Novel substance fki-0076 and process for producing the same
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
AU2002246373A1 (en) Cupua seed-origin fat, process for producing the same and use thereof